Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 2
1964 2
1969 1
1971 3
1972 5
1974 2
1975 1
1976 2
1977 2
1978 3
1979 5
1980 7
1981 6
1982 8
1983 7
1984 8
1985 9
1986 2
1987 8
1988 6
1989 6
1990 7
1991 7
1992 13
1993 9
1994 11
1995 8
1996 12
1997 5
1998 13
1999 6
2000 6
2001 5
2002 12
2003 13
2004 13
2005 12
2006 16
2007 15
2008 17
2009 27
2010 29
2011 22
2012 30
2013 20
2014 16
2015 23
2016 22
2017 30
2018 19
2019 26
2020 32
2021 43
2022 24
Text availability
Article attribute
Article type
Publication date

Search Results

607 results
Results by year
Filters applied: . Clear all
Page 1
Pathways and mechanisms of venetoclax resistance.
Bose P, Gandhi V, Konopleva M. Bose P, et al. Among authors: gandhi v. Leuk Lymphoma. 2017 Sep;58(9):1-17. doi: 10.1080/10428194.2017.1283032. Epub 2017 Jan 31. Leuk Lymphoma. 2017. PMID: 28140720 Free PMC article. Review.
Ibrutinib and Venetoclax for First-Line Treatment of CLL.
Jain N, Keating M, Thompson P, Ferrajoli A, Burger J, Borthakur G, Takahashi K, Estrov Z, Fowler N, Kadia T, Konopleva M, Alvarado Y, Yilmaz M, DiNardo C, Bose P, Ohanian M, Pemmaraju N, Jabbour E, Sasaki K, Kanagal-Shamanna R, Patel K, Jorgensen J, Garg N, Wang X, Sondermann K, Cruz N, Wei C, Ayala A, Plunkett W, Kantarjian H, Gandhi V, Wierda W. Jain N, et al. Among authors: gandhi v. N Engl J Med. 2019 May 30;380(22):2095-2103. doi: 10.1056/NEJMoa1900574. N Engl J Med. 2019. PMID: 31141631 Clinical Trial.
Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia: A Nonrandomized Phase 2 Trial.
Jain N, Keating M, Thompson P, Ferrajoli A, Burger JA, Borthakur G, Takahashi K, Estrov Z, Sasaki K, Fowler N, Kadia T, Konopleva M, Alvarado Y, Yilmaz M, DiNardo C, Bose P, Ohanian M, Pemmaraju N, Jabbour E, Kanagal-Shamanna R, Patel K, Wang W, Jorgensen J, Wang SA, Garg N, Wang X, Wei C, Cruz N, Ayala A, Plunkett W, Kantarjian H, Gandhi V, Wierda WG. Jain N, et al. Among authors: gandhi v. JAMA Oncol. 2021 Aug 1;7(8):1213-1219. doi: 10.1001/jamaoncol.2021.1649. JAMA Oncol. 2021. PMID: 34110383 Free PMC article. Clinical Trial.
LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in KRAS-Mutant Lung Adenocarcinoma.
Galan-Cobo A, Sitthideatphaiboon P, Qu X, Poteete A, Pisegna MA, Tong P, Chen PH, Boroughs LK, Rodriguez MLM, Zhang W, Parlati F, Wang J, Gandhi V, Skoulidis F, DeBerardinis RJ, Minna JD, Heymach JV. Galan-Cobo A, et al. Among authors: gandhi v. Cancer Res. 2019 Jul 1;79(13):3251-3267. doi: 10.1158/0008-5472.CAN-18-3527. Epub 2019 Apr 30. Cancer Res. 2019. PMID: 31040157 Free PMC article.
Massive Hemoptysis.
Rali P, Gandhi V, Tariq C. Rali P, et al. Among authors: gandhi v. Crit Care Nurs Q. 2016 Apr-Jun;39(2):139-47. doi: 10.1097/CNQ.0000000000000107. Crit Care Nurs Q. 2016. PMID: 26919675 Review.
Pulmonary Embolism.
Rali P, Gandhi V, Malik K. Rali P, et al. Among authors: gandhi v. Crit Care Nurs Q. 2016 Apr-Jun;39(2):131-8. doi: 10.1097/CNQ.0000000000000106. Crit Care Nurs Q. 2016. PMID: 26919674 Free article. Review.
607 results